Want to join the conversation?
For the first nine months of FY16, $NKE's cash used by financing activities was $2,045MM vs. $2,095MM for the same period of FY15. Cash used by financing activities was nearly flat as net proceeds of $981MM from the issuance of long-term debt in Oct. 2015 were mostly offset by increased common stock repurchases and dividends.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)